Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $233,482 - $290,553
1,762 New
1,762 $237,000
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $8,670 - $11,022
-63 Reduced 98.44%
1 $0
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $8,446 - $10,480
64 New
64 $10,000
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $133,857 - $169,368
-1,246 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $386,444 - $438,672
-3,632 Reduced 74.46%
1,246 $134,000
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $513,214 - $571,750
4,878 New
4,878 $549,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $353B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.